Therapies such as betibeglogene autotemcel have been “life-changing” for patients with β-thalassemia, according to Nora M. Gibson, MD, MSCE.
Nora M. Gibson, MD, MSCE
Advertisement
Articles by Nora M. Gibson, MD, MSCE
Advertisement
Latest Updated Articles
Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-ThalassemiaPublished: May 5th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
2
How Can Oncology Staffing Shortages Be Remedied?
3
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
